The integration of artificial intelligence (AI) with synthetic biology, often termed generative biology, presents significant challenges and concerns. As highlighted by Jim Thomas, a prominent figure in this area, this convergence raises questions about health, biodiversity, and regulatory oversight, especially with the upcoming UN Biodiversity Conference (CBD COP16). The rapid development of generative biology, primarily...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
